Islem Trabelsi

Ms. Islem Trabelsi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
IAIdris Nasir Abdullahi
Idris Nasir Abdullahi
JLJavier Latorre-Fernández
Javier Latorre-Fernández
RRRine Reuben
Rine Reuben
ITIslem Trabelsi
Islem Trabelsi
CGCarmen González-Azcona
Carmen González-Azcona
Carmen TorresCarmen Torres
Carmen Torres
Methicillin resistance, mediated by the mecA gene in staphylococci and mammaliicocci, has caused tremendous setbacks in the use of antibiotics in human and veterinary medicine due to its high potential of presenting the multidrug resistance (MDR) phenotype. Three other mec analogs exist, of which the mecC has evolutionary been associated with methicillin-resistant Staphylococcus aureus (MRSA) in wild animals, thus loosely referred to as the wild MRSA. In this study, we present an epidemiological review and genomic analysis of non-aureus staphylococci and mammaliicocci that carry the mecC-mediated methicillin resistance trait determine whether this trait has any relevant link with the One Health niches. All previous studies (2007 till 2023) that described the mecC gene in non-aureus staphylococci and mammaliicocci were obtained from bibliometric databases, reviewed, and systematically analyzed to obtain the antimicrobial resistance (AMR) and virulence determinants, mobilome, and other genetic contents. Moreover, core genome single-nucleotide polymorphism analysis was used to assess the relatedness of these strains. Of the 533 articles analyzed, only 16 studies (on livestock, environmental samples, milk bulk tanks, and wild animals) were eligible for inclusion, of which 17 genomes from 6 studies were used for various in silico genetic analyses. Findings from this systematic review show that all mecC-carrying non-aureus staphylococci were resistant to only beta-lactam antibiotics and associated with the classical SCCmec XI of S. aureus LGA251. Similarly, two studies on wild animals reported mecC-carrying Mammaliicoccus stepanovicii associated with SCCmec XI. Nevertheless, most of the mecC-carrying Mammaliicoccus species presented an MDR phenotype (including linezolid) and carried the SCCmec-mecC hybrid associated with mecA. The phylogenetic analysis of the 17 genomes revealed close relatedness (<20 SNPs) and potential transmission of M. sciuri and M. lentus strains in livestock farms in Algeria, Tunisia, and Brazil. Furthermore, closely related M. sciuri strains from Austria, Brazil, and Tunisia (<40 SNPs) were identified. This systematic review enhances our comprehension of the epidemiology and genetic organization of mecC within the non-aureus staphylococci and mammaliicocci. It could be hypothesized that the mecC-carrying non-aureus staphylococci are evolutionarily related to the wild MRSA-mecC. The potential implications of clonal development of a lineage of mecA/mecC carrying strains across multiple dairy farms in a vast geographical region with the dissemination of MDR phenotype is envisaged. It was observed that most mecC-carrying non-aureus staphylococci and mammaliicocci were reported in mastitis cases. Therefore, veterinarians and veterinary microbiology laboratories must remain vigilant regarding the potential existence of mecA/mecC strains originating from mastitis as a potential niche for this resistance trait.

22 March 2025 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
IAIdris Nasir Abdullahi
Idris Nasir Abdullahi
ITIslem Trabelsi
Islem Trabelsi
OBJECTIVES: In May 2024, the World Health Organization classified carbapenem (CARB)- and third-generation cephalosporin (3GC) resistance (R) in Escherichia coli as a critical priority, whereas colistin (COL) is a “last resort” antibiotic for their treatment. This meta-analysis evaluated the pooled prevalence, high-risk lineages, genetic relatedness, and mechanisms of CARBR, COLR, and 3GCR in E. coli from healthy humans and animals.METHODS: We conducted a systematic review and meta-analyses following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria on all eligible studies that reported the analysis of E. coli, and antimicrobial susceptibility to CARB, COL and 3GC in E. coli from gut samples of clinically healthy humans, livestock, and pets from June 2014 to June 2024. Random-effect models and conserved signature indels phylogeny 1.4 were used to determine pooled prevalence rates (PPs) and the relatedness of publicly available E. coli genomes, respectively.RESULTS: Of the 5,034 identified articles, 64 studies were deemed eligible. The overall PPs of 3GCR, CARBR, and COLR E. coli were 22.5% (95% confidence interval [CI], 17.5 to 28.3), 2.2% (95% CI, 1.0 to 4.7), and 15.5% (95% CI, 10.8 to 21.8), respectively. The PPs of 3GCR-, COLR- and CARBR E. coli significantly varied by hosts, continent, and year of studies (p<0.05). Diverse E. coli lineages were found, including 13 high-risk E. coli sequence types (STs), within which ST10 predominated. Phylogenomic analyses produced 4 clusters of related CARBR- and COLR E. coli strains (<25 single nucleotide polymorphism): ST940-blaOXA-181 from humans in Lebanon, ST617-mcr-1 from pigs in China, ST46-mcr-1 from poultry in Tanzania, and ST1720-mcr-1 from goats in France.CONCLUSIONS: COLR and 3GCR are more frequent than CARBR in gut E. coli. These 10-year epidemiological data highlight the persistence and transmission of critical priority and high-risk E. coli strains in healthy humans and animals, raising significant One Health concerns.

30 April 2025 in Avian Pathology
Verified
Journal Article
Closed access
IAIdris Nasir Abdullahi
Idris Nasir Abdullahi
ITIslem Trabelsi
Islem Trabelsi
Birds harbor Enterococcus faecium and Enterococcus faecalis as gut commensals but could acquire and transmit high-priority strains. Following the PRISMA guidelines, eligible studies that reported the antimicrobial resistance (AMR) profiles of E. faecium and E. faecalis from gut samples of food-producing (FPBs) and wild birds (WBs) published from 2005 to 2024 were screened from major bibliographic databases. Random-effect models were used to determine the pooled prevalences (PPs) of vancomycin (VANR), ampicillin (AMPR), and linezolid (LZDR) resistant E. faecium and E. faecalis from non-duplicated gut samples of food-producing (FPBs) and wild birds (WBs). Of the 36 eligible studies, the overall PP of VANR-E. faecium and VANR-E. faecalis were 1.8% and 0.7%, respectively. AMPR-E. faecium and AMPR-E. faecalis were 1.6% and 0.6%, respectively. LZDR-E. faecium and LZDR-E. faecalis were 1% and 0.8%, respectively. Subgroup analyses revealed significant temporal variations in the PPs of VANR-E. faecium (p < 0.05). FPBs had significantly higher PPs of VANR, AMPR and LZDR E. faecium and E. faecalis than WBs (p < 0.05). Healthcare-associated vanA-carrying E. faecium lineages from WBs (ST16, ST17, ST18, and ST412) and optrA-carrying E. faecalis lineages (ST32, ST59, ST330) from FPBs were identified. In FPBs, Egypt had the highest PP of VANR-E. faecium (11.9%) and LZDR-E. faecalis (2.8%). Conversely, the USA had the highest PP of VANR-E. faecium in WBs (2.4%). A higher frequency of vancomycin- than linezolid-resistant strains exists, and VANR-E. faecium are disproportionately distributed based on bird species, years of study, and countries, indicating varied selection pressure. Significantly higher prevalence of VANR-E. faecium than VANR-E. faecalis was found, highlighting the higher capacity of E. faecium to acquire ampicillin and vancomycin resistance in birds.